Gabriel Balmus

Has grant

Principal Investigator

University of Cambridge
Country flagUnited Kingdom

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

The role of DNA Damage in Huntington's Disease

Open Date: 2023-09-01

Close Date: 2025-09-01

Grant: Open

The role of DNA Damage in neurodegeneration

Open Date: 2023-06-01

Close Date: 2028-03-01

Articles (10)

Year:

2026

Year:

2026

Expanded CAG alleles in the huntingtin ( HTT ) gene that cause the neurodegenerative disorder Huntington’s disease (HD) are genetically unstable and continue to expand somatically throughout life, driving HD onset and progression. MSH3, a DNA mismatch repair protein, modifies HD onset and progression by driving this somatic CAG repeat expansion process. MSH3 is relatively tolerant of loss-of-function variation in humans, making it a potential therapeutic target. Here, we show that an MSH3 -targeting antisense oligonucleotide (ASO) effectively engaged with its RNA target in induced pluripotent stem cell (iPSC)–derived striatal neurons obtained from a patient with HD carrying 125 HTT CAG repeats (the 125 CAG iPSC line). ASO treatment led to a dose-dependent reduction of MSH3 and subsequent stalling of CAG repeat expansion in these striatal neurons. Bulk RNA sequencing revealed a safe profile for MSH3 reduction, even when reduced by >95%. Maximal knockdown of MSH3 also effectively slowed CAG repeat expansion in striatal neurons with an otherwise accelerated expansion rate, derived from the 125 CAG iPSC line where FAN1 was knocked out by CRISPR-Cas9 editing. Last, we created a knock-in mouse model expressing the human MSH3 gene and demonstrated effective in vivo reduction in human MSH3 after ASO treatment. Our study shows that ASO-mediated MSH3 reduction can prevent HTT CAG repeat expansion in HD 125 CAG iPSC–derived striatal neurons, highlighting the therapeutic potential of this approach.

Year:

2025

Antigen receptor diversity depends on the assembly of variable (V), diverse (D), and joining (J) exons in genes encoding immunoglobulins (Igs) and T cell receptors (TCRs). During V(D)J recombination, DNA double-strand breaks (DSBs) introduced by the RAG1/2 nuclease complex are repaired by the process of nonhomologous end-joining (NHEJ). We hypothesized that functional redundancies between NHEJ and the chromatin DSB response, which depends on the kinase ATM, potentially masked the activity of additional factors that regulate V(D)J recombination. We performed targeted CRISPR-Cas9 knockout screens for genes implicated in V(D)J recombination in pro-B cells that were either untreated or treated with an ATM inhibitor. We found that loss of the RNA/DNA helicase senataxin (SETX) impaired V(D)J recombination and led to the formation of aberrant hybrid joints between coding ends and signal ends, both in vitro and in mice. The loss of SETX in a background deficient in the NHEJ factor XLF or in which ATM was inhibited led to substantial impairment of V(D)J recombination and to the presence of unsealed coding ends. SETX limited aberrant activation-induced cytidine deaminase (AID)–induced DNA end-joining between Igh -containing alleles during the process of class-switch recombination. Together, our findings reveal a previously uncharacterized role for SETX in promoting recombination fidelity during antigen receptor gene diversification.

Year:

2025

Sustained smouldering, or low-grade activation, of myeloid cells is a common hallmark of several chronic neurological diseases, including multiple sclerosis 1 . Distinct metabolic and mitochondrial features guide the activation and the diverse functional states of myeloid cells 2 . However, how these metabolic features act to perpetuate inflammation of the central nervous system is unclear. Here, using a multiomics approach, we identify a molecular signature that sustains the activation of microglia through mitochondrial complex I activity driving reverse electron transport and the production of reactive oxygen species. Mechanistically, blocking complex I in pro-inflammatory microglia protects the central nervous system against neurotoxic damage and improves functional outcomes in an animal disease model in vivo. Complex I activity in microglia is a potential therapeutic target to foster neuroprotection in chronic inflammatory disorders of the central nervous system 3 .

Year:

2024

Genomic instability arising from defective responses to DNA damage 1 or mitotic chromosomal imbalances 2 can lead to the sequestration of DNA in aberrant extranuclear structures called micronuclei (MN). Although MN are a hallmark of ageing and diseases associated with genomic instability, the catalogue of genetic players that regulate the generation of MN remains to be determined. Here we analyse 997 mouse mutant lines, revealing 145 genes whose loss significantly increases ( n = 71) or decreases ( n = 74) MN formation, including many genes whose orthologues are linked to human disease. We found that mice null for Dscc1 , which showed the most significant increase in MN, also displayed a range of phenotypes characteristic of patients with cohesinopathy disorders. After validating the DSCC1 -associated MN instability phenotype in human cells, we used genome-wide CRISPR–Cas9 screening to define synthetic lethal and synthetic rescue interactors. We found that the loss of SIRT1 can rescue phenotypes associated with DSCC1 loss in a manner paralleling restoration of protein acetylation of SMC3. Our study reveals factors involved in maintaining genomic stability and shows how this information can be used to identify mechanisms that are relevant to human disease biology 1 .

Year:

2024

Autophagy is a conserved pathway where cytoplasmic contents are engulfed by autophagosomes, which then fuse with lysosomes enabling their degradation. Mutations in core autophagy genes cause neurological conditions, and autophagy defects are seen in neurodegenerative diseases such as Parkinson’s disease and Huntington’s disease. Thus, we have sought to understand the cellular pathway perturbations that autophagy-perturbed cells are vulnerable to by seeking negative genetic interactions such as synthetic lethality in autophagy-null human cells using available data from yeast screens. These revealed that loss of proteasome and nuclear pore complex components cause synergistic viability changes akin to synthetic fitness loss in autophagy-null cells. This can be attributed to the cytoplasm-to-nuclear transport of proteins during autophagy deficiency and subsequent degradation of these erstwhile cytoplasmic proteins by nuclear proteasomes. As both autophagy and cytoplasm-to-nuclear transport are defective in Huntington’s disease, such cells are more vulnerable to perturbations of proteostasis due to these synthetic interactions.

Year:

2024

Year:

2024

The naked mole-rat (NMR; Heterocephalus glaber ) is a eusocial subterranean rodent with a highly unusual set of physiological traits that has attracted great interest amongst the scientific community. However, the genetic basis of most of these traits has not been elucidated. To facilitate our understanding of the molecular mechanisms underlying NMR physiology and behaviour, we generated a long-read chromosomal-level genome assembly of the NMR. This genome was subsequently annotated and incorporated into multiple whole genome alignments in the Ensembl database. Our long-read assembly identified thousands of repeats and genes that were previously unassembled in the NMR and improved the results of routinely used short-read sequencing-based experiments such as RNA-seq, snRNA-seq, and ATAC-seq. We identified several spermatozoa related gene losses that may underlie the unique degenerative sperm phenotype in NMRs ( IRGC , FSCB , AKAP3 , MROH2B , CATSPER1 , DCDC2C , ATP1A4 , TEKT5 , and ZAN ), and an additional gene loss related to the established NK-cell absence in NMRs (PILRB). We resolved several tandem duplications in genes related to pathways underlying unique NMR adaptations including hypoxia tolerance, oxidative stress, and nervous system protection ( TINF2 , TCP1 , KYAT1 ). Lastly, we describe our ongoing efforts to generate a reference telomere-to-telomere assembly in the NMR which includes the resolution of complex gene families. This new reference genome should accelerate the discovery of the genetic underpinnings of NMR physiology and adaptation.

Year:

2024

Year:

2023

Collaborators (25)

Delphine Larrieu

Principal Investigator, Sir Henry Dale fellow

University of Cambridge

UNITED KINGDOM
View details

Lidia Wrobel

Group Leader

International Institute of Molecular and Cell Biology

POLAND
View details

Ian G. Ganley

Academic, Professor (Teaching and Research) of Cellular Homeostasis

University of Dundee

UNITED KINGDOM
View details

Sarah J. Tabrizi

Joint Head, Department of Neurodegenerative Disease

-

UNITED KINGDOM
View details

Michael Flower

University College London

UNITED KINGDOM
View details

Ewan Smith

Head of Department

University of Cambridge

UNITED KINGDOM
View details

Hiran Prag

The University of Manchester

UNITED KINGDOM
View details

Richard Frock

Assistant Professor

Stanford University School of Medicine

UNITED STATES
View details

Melissa Holmes

Associate Professor

University of Toronto Mississauga

CANADA
View details

Alexandra Nicaise

Assistant Professor

University of Arkansas for Medical Sciences

UNITED STATES
View details

Evan Eichler

Howard Hughes Medical Institute

UNITED STATES
View details

Ludovic Deriano

Principal Investigator

Institut Pasteur

FRANCE
View details

Monica Abrudan

University of Oxford

UNITED KINGDOM
View details

Diana Laird

University of California, San Francisco

UNITED STATES
View details

David Adams

Senior Group Leader (and Interim Programme Head)

Wellcome Sanger Institute

UNITED KINGDOM
View details

Alexander Nater

Staff scientist

University of Bern

SWITZERLAND
View details

Cory Willis

Assistant Professor

University of Arkansas for Medical Sciences

UNITED STATES
View details

Marc Ciosi

University of Glasgow

UNITED KINGDOM
View details

Joseph Hamilton

University College London

UNITED KINGDOM
View details

Trevor J. Pugh

Professor

University Health Network

CANADA
View details

Stefan Geyer

Associate Professor

Medical University of Vienna

AUSTRIA
View details

Michael Wilson

University of Toronto

CANADA
View details

Ruth Verstraten

Wellcome Sanger Institute

UNITED KINGDOM
View details

Michael Murphy

Professor of Mitochondrial Redox Biology

University of Cambridge

UNITED KINGDOM
View details

Rebecca E McIntyre

Principal Staff Scientist

Wellcome Sanger Institute

UNITED KINGDOM
View details